Abstract
2211MO Uncovering the mechanisms of persistent disease in RET-altered thyroid cancers: Insights from patient-derived xenograft models treated with selective RET inhibitors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have